VYNE THERAPEUTICS INC (VYNE:NASDAQ)
$0.651 0.0181 (2.8599%)
Analysed VYNE THERAPEUTICS INC (VYNE:NASDAQ) News Sources
Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Surpass Estimates
06-08-2025
yahoo.com
Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates
11-08-2025
yahoo.com
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates
12-08-2025
yahoo.com
VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update
14-08-2025
yahoo.com
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
14-08-2025
yahoo.com
VYNE Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
18-08-2025
yahoo.com
VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update
06-11-2025
yahoo.com
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates
06-11-2025
yahoo.com
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement
17-12-2025
yahoo.com
BC-Most Active Stocks
17-12-2025
yahoo.com
What is the current price of VYNE THERAPEUTICS INC (VYNE:NASDAQ)?
The current price of VYNE THERAPEUTICS INC (VYNE:NASDAQ) is $0.651.
VYNE THERAPEUTICS INC (VYNE:NASDAQ) absolute price change since previous trading day?
The absolute price change of VYNE THERAPEUTICS INC (VYNE:NASDAQ) since the previous trading day is $0.0181.
VYNE THERAPEUTICS INC (VYNE:NASDAQ) percentage price change since previous trading day?
The percentage price change of VYNE THERAPEUTICS INC (VYNE:NASDAQ) since the previous trading day is 2.8599%.
What is the most recent average sentiment score for VYNE THERAPEUTICS INC (VYNE:NASDAQ)?
The most recent average sentiment score for VYNE THERAPEUTICS INC (VYNE:NASDAQ) is 55 out of 100.
What is the most recent average sentiment for VYNE THERAPEUTICS INC (VYNE:NASDAQ)?
The most recent sentiment for VYNE THERAPEUTICS INC (VYNE:NASDAQ) is .
SEC-8K** Filing Available For VYNE THERAPEUTICS INC (VYNE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.